NCT01127126
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Department of Obstetrics and Gynecology Zurich, Switzerland
Clinical trial condition
Urinary Bladder, Overactive
Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.
609 public trials
62 recruiting studies
Urinary Bladder, Overactive trial results
NCT00798434
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
- Locations
-
- Pfizer Investigational Site Vienna, Austria
- Pfizer Investigational Site Antwerp, Belgium
- Pfizer Investigational Site Edegem, Belgium
- Pfizer Investigational Site Ghent, Belgium
NCT00224146
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
- Locations
-
- Mobile, Alabama, United States
- Tucson, Arizona, United States
- Torrance, California, United States
- Rocky Hill, Connecticut, United States
NCT00857896
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
- Locations
-
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Long Beach, California, United States
- Pfizer Investigational Site Overland Park, Kansas, United States
- Pfizer Investigational Site Overland Park, Kansas, United States
NCT00862745
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +13 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
Completed
A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder
NCT00189800
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Anyang, South Korea
- Bucheon-si, South Korea
- Busan, South Korea
- Cheonan, South Korea
NCT00985387
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Bucheon-si, South Korea
- Bucheon-si, South Korea
- Busan, South Korea
- Busan, South Korea
NCT01408771
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
Not specified
NCT00561951
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Kowloon, Hong Kong
- Pfizer Investigational Site Shatin, Hong Kong
- Pfizer Investigational Site Nagoya, Aichi-ken, Japan
- Pfizer Investigational Site Chuo-ku, Chiba-shi, Chiba, Japan
NCT00507169
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
Not specified